Quick Verdict

Retatrutide for maximum weight loss in advanced obesity (≥24% body weight in Phase 2). Semaglutide for a proven, globally available, cardiovascular-safe starting point. Tirzepatide sits between them as the current FDA-approved sweet spot.

Side-by-Side Analysis

DimensionSemaglutideRetatrutide
MechanismGLP-1 receptor agonism mimics the incretin hormone to reduce appetite, slow gastric emptying, improve insulin sensitivity, and provide cardiovascular protection.Multi-receptor activation for appetite suppression, fat oxidation, energy expenditure.
Primary BenefitsFat loss, appetite control, cardiovascular benefitsSuperior body recomposition, massive fat loss, metabolic health
Typical Dose250–250mcg2000–2000mcg
RouteSubQSubQ
Frequency1x/wk1x/wk
Half-Life168 hours144 hours
FDA StatusApprovedApproved
Evidence Gradevery-strongstrong
Key Studies20+ indexed20+ indexed
Lowest Price$47.99 / 5mg via Amino Club$69.99 / 10mg via Amino Club

Which one should you choose?

Retatrutide is better for maximizing total weight loss and resolving fatty liver, while Semaglutide is a proven, gentler starting point. Semaglutide is a single-agonist (GLP-1) that works primarily by delaying gastric emptying and signaling fullness to the brain. Retatrutide is a triple-agonist (GLP-1, GIP, Glucagon) that adds direct fat-burning via increased energy expenditure (thermogenesis). Choose Semaglutide if you are new to GLP-1s and want the most established safety profile. Choose Retatrutide if you have severe obesity, need to lose >20% of body weight, or want to avoid the extreme fatigue sometimes associated with Semaglutide. Tirzepatide is often the best middle ground between the two.

Who Should Choose Semaglutide?

Choose Semaglutide if you:

  • Are starting a GLP-1 protocol for the first time and want maximum safety data
  • Have established cardiovascular disease (SELECT trial evidence)
  • Cost or insurance coverage is a limiting factor
  • Need a globally available, prescription-accessible option

Who Should Choose Retatrutide?

Choose Retatrutide if you:

  • Have severe obesity (BMI >40) that has not responded to dual agonists
  • Want to study glucagon-driven thermogenesis in combination with GLP-1/GIP
  • Are comfortable with Phase 2 research-stage compounds without Phase 3 approval
  • Are targeting MASLD (metabolic liver disease) alongside weight loss

Can you stack Semaglutide + Retatrutide?

Do NOT stack Semaglutide and Retatrutide — they share the GLP-1 receptor. Concurrent use creates dangerous additive stimulation with compounded GI toxicity and hypoglycemia risk. Use one GLP-1-class agent at a time.

Vendor Pricing

· Affiliate links · Prices verified 2026

Semaglutide

2 vendors
Amino Club Best Value
5mg vial · $9.60/mg
$47.99Buy
Limitless Life
5mg vial · $11.60/mg
$58.00Buy

Retatrutide

1 vendor
Amino ClubEditor's Pick Best Value
10mg vial · $7.00/mg
$69.99Buy

Affiliate disclosure: PeptiDex may earn a commission from purchases via vendor links at no extra cost to you. See our methodology.

Frequently Asked Questions

Phase 2 Retatrutide data shows ~24% body weight loss at 24 weeks vs Semaglutide's ~15% at max dose (STEP 1, 68 weeks). Retatrutide is not yet Phase 3 approved; Semaglutide is FDA-approved and widely available.

Related Comparisons

Research Use Only — Not Medical Advice

This comparison is provided for educational and research purposes only. It does not constitute medical, prescribing, or treatment advice. Clinical data cited here is sourced from published peer-reviewed trials and FDA labels. Consult a qualified healthcare professional before making any decisions about medications or research compounds. PeptiDex is an informational resource and does not sell pharmaceutical products.